EN | TR
E-ISSN: 2146-3077
Evaluation of the Impact of the COVID-19 Pandemic on Cystic Echinococcosis Indirect Hemagglutination Test Dynamics: A Single-center Experience
PDF
Cite
Share
Request
Original Investigation
VOLUME: 47 ISSUE: 3
P: 166-170
September 2023

Evaluation of the Impact of the COVID-19 Pandemic on Cystic Echinococcosis Indirect Hemagglutination Test Dynamics: A Single-center Experience

Turkiye Parazitol Derg 2023;47(3):166-170
DOI: 10.4274/tpd.galenos.2023.42104
Özlem Ulusan Bağcı
1. İzmir Katip Çelebi Üniversitesi, Atatürk Eğitim ve Araştırma Hastanesi, Tıbbi Mikrobiyoloji Laboratuvarı, İzmir, Türkiye
No information available.
No information available
Received Date: 31.10.2022
Accepted Date: 29.03.2023
Publish Date: 18.09.2023
PDF
Cite
Share
Request

ABSTRACT

Objective:

Cystic echinococcosis (CE) is one of the neglected tropical diseases announced by the World Health Organization. In the period entered with the Coronavirus disease-2019 pandemic, the fight against such diseases has become even more difficult. In our study, we aimed to make inferences about the effects of the pandemic on the diagnosis of the disease by evaluating the number and results of CE indirect hemagglutination test (IHA) before and during the pandemic.

Methods:

The number of IHA test requests and positivity rates in the 30-month periods before and after March 11, 2020, when the first case was seen in our country, were evaluated retrospectively. Statistical analysis was made with SPSS version 23 (SPSS, Chicago, IL, USA) program.

Results:

The results of 1444 patients before the pandemic and 870 patients during the pandemic period were examined. The difference between IHA positivity rates, which was found to be 18.49% before the pandemic and 14.6% during the pandemic, was statistically significant (p=0.016). The positivity rates of women and men were found to be statistically similar in both periods (pbefore=0.621, pafter=0.238). The age group with the highest IHA positivity rate was 20-39 in both periods, and the difference between the positivity rates of the age groups was statistically significant (p<0.001).

Conclusion:

A significant decrease was observed in the rate of IHA positivity during the pandemic period. The status of no increase in positivity rates despite a significant decrease in IHA tests makes us think that the diagnosis may be missed in some patients or that there could be disruptions in their follow-up. For this reason, in order to continue the fight successfully against CE, which is an important public health problem for our country, early diagnosis and regular follow-ups should be emphasized with educations, and the laboratory-clinician communication should be strengthened in order to use tests more efficiently.

Keywords: COVID-19, indirect hemagglutination test (IHA), cystic echinococcosis (CE), pandemic

References

1
da Silva AM. Human echinococcosis: a neglected disease. Gastroenterol Res Pract 2010; 2010: 583297.
2
D’Alessandro A, Rausch RL. New aspects of neotropical polycystic (Echinococcus vogeli) and unicystic (Echinococcus oligarthrus) echinococcosis. Clin Microbiol Rev 2008; 21: 380-401.
3
Kilimcioğlu AA, İnceboz T. Echinococcosis. In: Korkmaz M, Ok UZ, editors. Parazitolojide Laboratuvar. İzmir: Meta Basım-Türkiye Parazitoloji Derneği; 2011.p.293-306.
4
Ehrenberg JP, Zhou XN, Fontes G, Rocha EMM, Tanner M, Utzinger J. Strategies supporting the prevention and control of neglected tropical diseases during and beyond the COVID-19 pandemic. Infect Dis Poverty 2020; 9: 86.
5
Pawlowski Z, Eckert J, Vuitton D, Ammann RW, Kern P, Craig PS, et al. Echinococcosis in humans: clinical aspects, diagnosis and treatment,” in WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. In: Eckert J, Gemmel MA, Meslin FX, Pawlowski ZS, editors. World Health Organization and World Organization for Animal Health. Paris:France; 2001.p.20-66.
6
World Health Organization (cited 2022  September 28). Available from: https://www.who.int/news-room/fact-sheets/detail/echinococcosis.
7
Ok ÜZ, Kilimcioğlu AA, Özkol M. Türkiye’de İnsanlarda Kistik Ekinokokkoz [Cystic Echinococcosis in Humans in Turkey]. Mikrobiyol Bul 2020; 54: 510-22.
8
World Health Organization. Neglected Tropical Diseases (cited 2022 September 26). Available from: https://www.who.int/neglected_diseases/diseases/en/.
9
Craig PS, Budke CM, Schantz PM, Li T, Qiu J, Yang Y, et al. Human Echinococcosis: A Neglected Disease? Trop Med Health 2007; 35: 283-92.
10
World Health Organization. COVID-19: WHO issues interim guidance for implementation of NTD programmes (cited 2022 October 01). Available from: https://www.londonntd.org/news/covid-19-who-issues-interim-guidance-for-implementation-of-ntd-programmes.
11
de Souza DK, Picado A, Biéler S, Nogaro S, Ndung’u JM. Diagnosis of neglected tropical diseases during and after the COVID-19 pandemic. PLoS Negl Trop Dis 2020; 14: e0008587.
12
World Health Organization. The Potential Impact of Health Service Disruptions on the Burden of Malaria: A Modelling Analysis for Countries in Sub-Saharan Africa (cited 2022 October 01). Available from: https://www.who.int/publications/i/item/9789240004641
13
Kura K, Ayabina D, Toor J, Hollingsworth TD, Anderson RM. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies. Trans R Soc Trop Med Hyg 2021; 115: 236-44.
14
Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health 2020; 8: e1132-41. Erratum in: Lancet Glob Health 2021; 9: e23.
15
Zorbozan O. The Impact of COVID-19 Pandemic on Access to Healthcare: The Experience of the Diagnostic Parasitology Laboratory of Ege University. Turkiye Parazitol Derg 2022; 46: 124-8.
16
Głuchowska K, Dzieciątkowski T, Sędzikowska A, Zawistowska-Deniziak A, Młocicki D. The New Status of Parasitic Diseases in the COVID-19 Pandemic-Risk Factors or Protective Agents? J Clin Med 2021; 10: 2533.
17
Molyneux DH, Hotez PJ, Fenwick A. “Rapid-impact interventions”: how a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med 2005; 2: e336.
18
Aslan MH, Kurt A, Vural MK. The Investigation of Indirect Hemaglutınatıon (IHA) test results of patient with early diagnosis Cystic Echinococcosis. Van Med J 2019; 26: 158-61.
19
Alver O, Payaslıoğlu AM, Özakın C, Esen S. Laboratory Results of Cystic Echinococcosis in 2017 and 2018. Turkiye Parazitol Derg 2021; 45: 207-10.
20
Çitil BE, Tunçoğlu E, Erbil ÖF, Değirmenci M, Özenoğlu A, Sert H. Evaluation of Patients who were Prediagnosed As Cystic Echinococcosis by Using Indirect Haemagglutination Test (IHA) Technique in Adıyaman. Van Med J 2015; 22: 220-4.
21
Esenkaya Taşbent F, Yağcı B, Kadıyoran C, İyisoy MS. Comparative Evaluation of the Efficacy of Indirect Hemagglutination Test and Radiological Methods in the Pre-diagnosis of Cystic Echinococcosis. Turkiye Parazitol Derg 2021; 45: 22-7.
22
Delibaş SB, Ozkoç S, Sahin S, Aksoy U, Akisü C. Evaluation of patients presenting with a suspicion of cystic echinococcosis to the serology laboratory of the Parasitology Department of Dokuz Eylül University Medical Faculty. Turkiye Parazitol Derg 2006; 30: 279-81.
23
Başer S, İsmayıl A, Maçin S. Evaluation of the Seropositivity of Patients with Cystic Echinococcosis in Konya, Turkey. J Contemp Med 2021; 11: 139-41.
2024 ©️ Galenos Publishing House